Piperine inhibits LPS induced expression of inflammatory mediators in RAW 264.7 cells

Cellular Immunology
2013.0

Abstract

The aim of the present study was to investigate the effects of piperine on the inflammatory responses to lipopolysaccharide (LPS) in RAW264.7 cells and the signal transduction pathways involved. RAW264.7 cells were pretreated with piperine at 10, 50 or 100 mu g/ml and subsequently stimulated with LPS (1 mu g/ml) for 24 h. We found that piperine inhibited the production of prostaglandin E2 (PGE2) and nitric oxide (NO) induced by LPS. Piperine significantly decreased LPS-stimulated gene expression and production of tumor necrosis factor-alpha (TNF alpha), inducible NO synthase (iNOS) and COX-2 in RAW264.7 cells. Piperine inhibited the LPS-mediated activation of nuclear factor-kappa B (NF-kappaB) by suppressing the degradation of inhibitor-kappa B proteins (I kappa B) and the translocations of p65 subunit of NF-kappa B from the cytosol to the nucleus. Our results demonstrate the anti-inflammatory activity of piperine in RAW264.7 cells; suggesting that piperine may be a potential agent in the treatment of inflammation. (C) 2013 Elsevier Inc. All rights reserved.

Knowledge Graph

Similar Paper

Piperine inhibits LPS induced expression of inflammatory mediators in RAW 264.7 cells
Cellular Immunology 2013.0
Alkaloids from Black Pepper (Piper nigrum L.) Exhibit Anti-Inflammatory Activity in Murine Macrophages by Inhibiting Activation of NF-κB Pathway
Journal of Agricultural and Food Chemistry 2020.0
Anti-Inflammatory Effect of Pristimerin on Lipopolysaccharide-Induced Inflammatory Responses in Murine Macrophages
Archives of Pharmacal Research 2013.0
Alkaloids from Piper longum L and their Anti‐inflammatory Properties
Chemistry & Biodiversity 2024.0
Development and mechanism investigation of a new piperlongumine derivative as a potent anti-inflammatory agent
Biochemical Pharmacology 2015.0
A Pharmacological Insight of Piperlongumine, Bioactive Validating Its Therapeutic Efficacy as a Drug to Treat Inflammatory Diseases
Russian Journal of Bioorganic Chemistry 2023.0
Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation
Pharmaceuticals 2021.0
Plumbagin inhibits LPS-induced inflammation through the inactivation of the nuclear factor-kappa B and mitogen activated protein kinase signaling pathways in RAW 264.7 cells
Food and Chemical Toxicology 2014.0
Schisantherin A Exhibits Anti-inflammatory Properties by Down-Regulating NF-κB and MAPK Signaling Pathways in Lipopolysaccharide-Treated RAW 264.7 Cells
Inflammation 2010.0
Fraxinellone Inhibits Lipopolysaccharide-Induced Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Expression by Negatively Regulating Nuclear Factor-kappa B in RAW 264.7 Macrophages Cells
Biological and Pharmaceutical Bulletin 2009.0